Candriam Equities L Biotech.R-H CHF Acc/ LU1269736754 /
| NAV2024-04-23 | Chg.+2.4300 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 191.4000CHF | +1.29% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016 | - | - | - | - | - | - | - | - | 3.81 | -8.64 | -3.97 | -2.99 | - |
| 2017 | 5.37 | 6.71 | -0.01 | 0.96 | -3.17 | 9.25 | 2.21 | 6.79 | 0.75 | -6.79 | -0.06 | 1.28 | +24.55% |
| 2018 | 6.46 | -4.80 | -2.39 | -3.41 | 4.34 | 0.58 | 4.21 | 3.87 | -2.28 | -14.26 | 3.88 | -8.61 | -13.65% |
| 2019 | 12.82 | 3.37 | -0.81 | -5.23 | -4.67 | 9.15 | -2.44 | -2.53 | -4.73 | 10.96 | 11.86 | 2.51 | +31.48% |
| 2020 | -5.43 | -1.60 | -5.43 | 12.23 | 9.44 | 1.20 | -3.00 | 0.78 | 0.58 | -2.71 | 9.32 | 2.87 | +17.67% |
| 2021 | 1.79 | -2.63 | -4.46 | 2.68 | -2.30 | 6.28 | -1.49 | 3.84 | -4.29 | 0.13 | -4.43 | 2.29 | -3.23% |
| 2022 | -10.64 | -1.64 | 5.83 | -7.32 | -4.11 | 3.15 | 4.61 | 1.26 | -2.38 | 6.20 | 5.78 | -3.39 | -4.31% |
| 2023 | 2.65 | -5.92 | -0.03 | 1.99 | -1.27 | 1.11 | -0.85 | -0.55 | -4.78 | -6.38 | 5.73 | 13.17 | +3.40% |
| 2024 | 1.22 | 1.02 | -0.28 | -6.27 | - | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 15.89% | 18.59% | 16.12% | 20.10% | 22.72% |
| Sharpe ratio | -1.11 | 1.22 | -0.33 | -0.29 | 0.05 |
| Best month | +13.17% | +13.17% | +13.17% | +13.17% | +13.17% |
| Worst month | -6.27% | -6.38% | -6.38% | -10.64% | -10.64% |
| Maximum loss | -11.49% | -11.49% | -16.87% | -29.52% | -31.53% |
| Outperformance | -5.08% | - | -3.25% | - | - |
All quotes in CHF
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Biotech.V US... | reinvestment | 1,949.4200 | +2.57% | +2.83% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 211.4500 | +5.40% | - | |
| Candriam Equities L Biotech.I-H ... | reinvestment | 1,955.1100 | +0.30% | -4.34% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 2,125.4199 | +5.66% | +15.45% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,289.8799 | +2.72% | +12.88% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 346.1400 | +3.43% | +16.75% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 311.7600 | +6.38% | +18.14% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 191.4000 | -1.38% | -5.43% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 1,748.7000 | +3.44% | +5.67% | |
| Candriam Equities L Biotech.N-H ... | reinvestment | 142.0600 | - | - | |
| Candriam Equities L Biotech.N US... | reinvestment | 569.2300 | +1.91% | +1.05% | |
| Candriam Equities L Biotech.I US... | reinvestment | 5,333.5898 | +2.45% | +2.45% | |
| Candriam Equities L Biotech.C-H ... | reinvestment | 187.6200 | +0.13% | -4.49% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 195.5200 | +0.99% | -2.13% | |
| Candriam Equities L Biotech.R US... | reinvestment | 253.5100 | +3.18% | +4.88% | |
| Candriam Equities L Biotech.C US... | reinvestment | 798.8100 | +2.29% | +2.34% | |
| Candriam Equities L Biotech.C US... | paying dividend | 733.7900 | +2.25% | +2.24% |
Performance
| YTD | -4.43% | ||
|---|---|---|---|
| 6 Months | +12.48% | ||
| 1 Year | -1.38% | ||
| 3 Years | -5.43% | ||
| 5 Years | +28.28% | ||
| Since start | +27.60% | ||
| Year | |||
| 2023 | +3.40% | ||
| 2022 | -4.31% | ||
| 2021 | -3.23% | ||
| 2020 | +17.67% | ||
| 2019 | +31.48% | ||
| 2018 | -13.65% | ||
| 2017 | +24.55% | ||
